Southlake, TX / Grand Prairie, TX — February 23, 2026 — BioStone Animal Health announced today that it has acquired the business assets of American Animal Health, Inc. (AAH), including AAH’s USDA-licensed manufacturing facility in Grand Prairie, Texas (Est. 315). The acquisition strengthens BioStone’s ability to serve veterinarians and producers with high-quality, herd-specific autogenous bacterins supported by established manufacturing expertise and a continued commitment to quality and regulatory compliance.
BioStone will continue production of AAH’s autogenous bacterins and maintain the standards of safety, quality control, and documentation that AAH customers have relied on for decades. BioStone is retaining key AAH personnel to ensure continuity of service, quality, and technical support for the autogenous program.
Continuity and Enhanced Support
BioStone’s autogenous bacterin program combines AAH’s established production experience with BioStone’s broader diagnostic technologies and customer support infrastructure. The company will continue to work closely with prescribing veterinarians to support herd and flock health programs, including multi-antigen formulations tailored to the pathogens identified in each case.
Key Highlights of the BioStone AAH Autogenous Bacterin Program
- Proven autogenous manufacturing experience built on AAH’s multi-decade track record
- Formulation flexibility, including multi-antigen combinations (up to five) as prescribed by veterinarians
- Refined processing protocols and quality controls supporting consistency, purity, and safety
- Predictable timelines to support vaccination program planning
- Competitive, practical pricing aligned with producer needs
Customer Transition and Orders
BioStone will contact existing AAH customers with ordering and contact details. Veterinarians with questions regarding the transition or upcoming orders are encouraged to reach out directly to the BioStone Autogenous Bacterin Service Department.
About BioStone Animal Health
BioStone Animal Health is a U.S.-based biotechnology company providing diagnostic technologies and veterinary biologics to support animal health programs. Through BioStone Animal Health and its affiliated businesses, the company supports veterinarians, laboratories, and producers with tools that inform disease management and herd health decisions.